https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:387-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:387-932007-01-01 00:00:002019-02-15 09:16:56Cell technologies in immunotherapy of cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / J. Immunother. 2007 Jan;30(1):116-22
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / J. Immunother. 2007 Jan;30(1):116-222007-01-01 00:00:002019-02-15 09:17:01Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:381-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Adv. Exp. Med. Biol. 2007;601:381-62007-01-01 00:00:002019-02-15 09:19:41Lymphocyte subpopulations in melanoma patients treated with dendritic cell vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Drugs Aging 2007;24(3):197-221
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Drugs Aging 2007;24(3):197-2212007-01-01 00:00:002019-02-15 09:24:11Advances in prostate cancer immunotherapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Thyroid 2007 Jan;17(1):53-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Thyroid 2007 Jan;17(1):53-82007-01-01 00:00:002019-02-15 08:53:25Results of a phase I clinical study using dendritic cell vaccinations for thyroid cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Free Radic. Res. 2007 Jan;41(1):73-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Free Radic. Res. 2007 Jan;41(1):73-812007-01-01 00:00:002007-01-01 00:00:00Gene expression in enhanced apoptosis of human lymphoma U937 cells treated with the combination of different free radical generators and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Jan;23(1):60-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Jan;23(1):60-22007-01-01 00:00:002007-01-01 00:00:00[Induction of specific CTL by DC from axillary lymph node of patients with breast cancer]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Tumori 2007 Jan-Feb;93(1):26-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Tumori 2007 Jan-Feb;93(1):26-302007-01-01 00:00:002007-01-01 00:00:00Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Bull Cancer 2007 Jan;94(1):23-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Bull Cancer 2007 Jan;94(1):23-312007-01-01 00:00:002007-01-01 00:00:00[Immunotherapy and malignant mesothelioma: clinical perspectives]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Vitam Horm 2007;76:463-91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Vitam Horm 2007;76:463-912007-01-01 00:00:002021-06-30 13:46:31Vitamin E analogues and immune response in cancer treatment
